Ground Swell Capital’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Ground Swell Capital’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-5,122	Closed	-$458K	–	137
2021 Q2	$458K	Buy	+5,122	New	+$433K	2.18%	8

Other funds holding SYNH

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Ground Swell Capital's SYNH Position: Q3 2021 in Review

Ground Swell Capital sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2021, closing a stake of 5,122 shares — an estimated $458K sold.

Ground Swell Capital first reported a position in SYNH in Q2 2021 and held it in 1 quarter. The position peaked at $458K in Q2 2021. 355 funds tracked by Wall St. Rank hold SYNH as of Q3 2021.

Ground Swell Capital reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2021 after selling out during the quarter.
Ground Swell Capital sold 5,122 Syneos Health, Inc. Class A Common Stock shares in Q3 2021, an estimated $458K.
Ground Swell Capital first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2021 and held it in 1 quarter.
Ground Swell Capital's Syneos Health, Inc. Class A Common Stock position peaked at $458K in Q2 2021.
355 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2021.

Based on Ground Swell Capital's 13F filing for Q3 2021, filed 12 Nov 2021.